In 2005 was created Qatar Investment Authority, which is appeared as Corporate Investor. The company was established in Asia in Qatar. The main department of described Corporate Investor is located in the Doha.
The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Property Management, Real Estate. Among the most popular portfolio startups of the fund, we may highlight Uber, Lu.com, Flipkart. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Qatar Investment Authority, startups are often financed by Kleiner Perkins, General Atlantic, Fuel Capital. The meaningful sponsors for the fund in investment in the same round are T. Rowe Price, SoftBank Investment Advisers, Palo Alto Investors. In the next rounds fund is usually obtained by Tiger Global Management, SeventySix Capital, Kleiner Perkins.
We also calculated 5 valuable employees in our database.
The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2019. The common things for fund are deals in the range of more than 100 millions dollars. Comparing to the other companies, this Qatar Investment Authority performs on 9 percentage points less the average number of lead investments. The top activity for fund was in 2019. The real fund results show that this Corporate Investor is 10 percentage points more often commits exit comparing to other companies. The average startup value when the investment from Qatar Investment Authority is more than 1 billion dollars.
Related Funds
Funds with similar focus
Fund Name | Location |
Aquitaine Science Transfer | France, New Aquitaine, Talence |
Axivate Capital | Amsterdam, Noord-Holland, The Netherlands |
Blindspot Ventures | - |
Company Ventures | New York, New York, United States |
Enterprise 100 | England, London, United Kingdom |
General Motors Investment Management | New York, New York, United States |
Global Health Strategies | New York, New York, United States |
ICwise | China, Shanghai |
Iris Ventures | France, Ile-de-France, Paris |
Kinghall Ventures | - |
Odyssey Research | Bismarck, North Dakota, United States |
Parrot | France, Ile-de-France, Paris |
Pfm Capital | Canada, Regina, Saskatchewan |
Qianying Zhanyi | China, Hangzhou, Zhejiang |
Suoni Zhongguo Zhixing Jijin | - |
University of Bristol | Bristol, England, United Kingdom |
Yongmao Yuanke Gong Mao | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Outpace Bio | $144M | 01 Aug 2024 | Seattle, Washington, United States | ||
Bright Peak Therapeutics | $90M | 11 Jun 2024 | Basel, Basel-City, Switzerland | ||
Entos | $50M | 24 Apr 2024 | Los Angeles, California, United States | ||
Precede Biosciences | $57M | 05 Oct 2023 | Boston, Massachusetts, United States | ||
Star Therapeutics | $90M | 05 Sep 2023 | South San Francisco, California, United States | ||
Oricell Therapeutics | $45M | 28 Feb 2023 | Shanghai, Shanghai, China | ||
Ensoma | $85M | 05 Jan 2023 | Boston, Massachusetts, United States | ||
JenaValve Technology | $100M | 31 Aug 2022 | Munich, Bavaria, Germany | ||
Senda Biosciences | $123M | 16 Aug 2022 | Cambridge, Massachusetts, United States |
– VerSe Innovation, the parent firm of Dailyhunt and Josh, raised $450m funding.
– The round was led by Siguler Guff, Baillie Gifford and others.
– Existing investors Sofina Group, Qatar Investment Authority and BCap participated in the round.
– The startup claimed that Josh has amassed over 115 million monthly active users, 56 million of whom use the app each day. Dailyhunt has amassed over 300 million monthly active users.
– Trendyol, an e-commerce platform based in Turkey, raised $1.5bn funding.
– The round was led by General Atlantic, SoftBank Vision Fund 2, Princeville Capital and sovereign wealth funds, ADQ (UAE) and Qatar Investment Authority.
– The company plans to continue investing in nationwide infrastructure, technology and logistics and toward accelerating digitalization of Turkish SMEs.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Outpace Bio | $144M | 01 Aug 2024 | Seattle, Washington, United States | ||
Bright Peak Therapeutics | $90M | 11 Jun 2024 | Basel, Basel-City, Switzerland | ||
Entos | $50M | 24 Apr 2024 | Los Angeles, California, United States | ||
Precede Biosciences | $57M | 05 Oct 2023 | Boston, Massachusetts, United States | ||
Star Therapeutics | $90M | 05 Sep 2023 | South San Francisco, California, United States | ||
Oricell Therapeutics | $45M | 28 Feb 2023 | Shanghai, Shanghai, China | ||
Ensoma | $85M | 05 Jan 2023 | Boston, Massachusetts, United States | ||
JenaValve Technology | $100M | 31 Aug 2022 | Munich, Bavaria, Germany | ||
Senda Biosciences | $123M | 16 Aug 2022 | Cambridge, Massachusetts, United States |